CLINICAL_TRIALS
trial_result
· 2022-11-09
Clinical Trial Update: Beta Blocker De-prescription Following Coronary Artery Bypass Graft Surgery (BEEFBURGER Trial). [Phase 4]
Summary
A Phase 4 trial update on de-prescribing beta blockers after coronary artery bypass graft surgery, investigating safety/efficacy implications of reducing beta-b…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Saskatchewan | Conditions: Coronary Artery Disease, Acute Myocardial Infarction | Phase 4 | Status: UNKNOWN